OTLKW (OTLKW) News
Follow OTLKW (OTLKW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Con
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
REGULATION | Sep 10, 2026, 01:10 PM UTC
L
Outlook Therapeutics appoints CFO Kevin Lundquist
Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it prepares for a U.S. commercial launch of LYTENAVA.
EQUITY | Aug 27, 2026, 08:06 PM UTC
L
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
EQUITY | Aug 27, 2026, 01:01 PM UTC
L
Outlook Therapeutics reports FY2026 Q3 results; highlights LYTENAVA FDA approval
Outlook Therapeutics (OTLKW) reports Third Quarter Fiscal Year 2026 financial results and a business update highlighting FDA approval of LYTENAVA™.
EARNINGS | Aug 14, 2026, 11:15 AM UTC
L
Outlook Therapeutics prices $55.0 million common stock and warrants offering
Outlook Therapeutics announces the pricing of a $55.0 million public offering of common stock and warrants, selling $55.0 million total under the priced terms.
EQUITY | Aug 13, 2026, 01:45 AM UTC
L
OTLK OTLKW - Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
OTLK OTLKW - Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
EQUITY | Aug 12, 2026, 08:02 PM UTC
L
OTLK OTLKW - Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and
OTLK OTLKW - Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026
EARNINGS | Aug 06, 2026, 12:45 PM UTC